NCT04240535: A reported trial by Amir Moradi MD, MBA
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04240535 |
|---|---|
| Title | A Single Center, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 31, 2020 |
| Completion date | May 31, 2020 |
| Required reporting date | May 31, 2021, midnight |
| Actual reporting date | April 2, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |